key: cord-0839374-e4e2ookz
authors: Scarci, Marco; Raveglia, Federico
title: Commentary: Thoracic Surgery in COVID-19 Patients is not a Taboo: A Change of Mind and Correct Timing are Essential in COVID-19 Surgical Complications Management.
date: 2021-02-04
journal: J Thorac Cardiovasc Surg
DOI: 10.1016/j.jtcvs.2021.01.121
sha: 95e5efff0d072db6d2a39f616f64715385600b3f
doc_id: 839374
cord_uid: e4e2ookz

nan

In the last 10 months, with the pandemic advent, thoracic surgeons were forced to split their 9 attention between patients with complications from Covid-19 infection and urgent oncological 10 cases. The most striking challenge, especially at the beginning of the emergency, was that, as 11 hospitals' COVID-19 population increased and resources were stretched very thin, surgeons were 12 faced with the need to also provide care for respiratory complications in an infective environment 13 they were not used to (1) . At the same time, it has also been shown that the development of 14 symptomatic COVID-19 during the postoperative period is a dramatic event highly correlated with 15 death (2). Therefore, surgeons had to bear the brunt of the infection on multiple fronts: dealing with 16 respiratory complications in both medical patients and those who underwent lung cancer resection. 17

Our area, Lombardy region, was the most affected in Europe during the first wave and indeed we 18 were faced with 6 deaths out of 12 patients with developed COVID-19 in the postoperative period 19 for lung cancer, but also many complications in ventilated and not-ventilated patients 20 (pneumothoraces with ongoing airleaks, empyemas, chest wall hematoma and pneumatocele) and 21 an high number (around 20%) of infected healthcare providers. 22

Unfortunately, at the beginning of the pandemic, the poor understanding of the actual outcomes of 23 surgery in infected patients, has encouraged a conservative rather than operative approach. were discharged home but one pneumonectomy, who is still in intensive care for severe pneumonia 33 and sepsis. Notably, this patient was referred to us when general conditions were already worsened 34 and on ECMO, thus reinforcing the idea that early referral and treatment of complications is 35 advantageous for patients. In our opinion, this is the real key point of the article: as Authors 36

showed, thoracic surgery is feasible for patients with COVID-19 and selected complications, but 37 correct timing is mandatory. These patients are usually in poor general conditions because of 38 prolonged COVID-19 course, therefore at the onset of any complications potentially requiring 39 surgery, this should be promptly considered without further delay due to the potential infective risk, 40 especially now that the Authors proved that this is very limited with correct donning of protective 41 personal equipment. 42 J o u r n a l P r e -p r o o f

Commentary: The double responsibility of the thoracic surgeon at the 44 time of the pandemic: A perspective from the North of Italy

Clinical course of 47 coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis

Thoracic Surgery Outcomes for Patients 50 with Coronavirus Disease 2019 (COVID-19)